Aithal GP - Search Results

1

Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort^☆" [J Hepatol (2020) 505-515].

Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, Burt AD, Bedossa P, Palmer J, Liu YL, Aithal GP, Allison M, Yki-Järvinen H, Vacca M, Dufour JF, Invernizzi P, Prati D, Ekstedt M, Kechagias S, Francque S, Petta S, Bugianesi E, Clement K, Ratziu V, Schattenberg JM, Valenti L, Day CP, Cordell HJ, Daly AK; EPoS Consortium Investigators. Anstee QM, et al. Among authors: aithal gp. J Hepatol. 2023 May;78(5):1085-1086. doi: 10.1016/j.jhep.2023.02.028. Epub 2023 Mar 13. J Hepatol. 2023. PMID: 36922251 No abstract available.

2

CYP2C9 polymorphism and warfarin dose requirements.

Daly AK, Day CP, Aithal GP. Daly AK, et al. Among authors: aithal gp. Br J Clin Pharmacol. 2002 Apr;53(4):408-9. doi: 10.1046/j.1365-2125.2002.01572_6.x. Br J Clin Pharmacol. 2002. PMID: 11966680 Free PMC article. No abstract available.

3

Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity.

Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JB, Alexander G, Kenna JG, Caldwell J, Day CP. Aithal GP, et al. Hepatology. 2004 May;39(5):1430-40. doi: 10.1002/hep.20205. Hepatology. 2004. PMID: 15122773

4

Genetic regulation of warfarin metabolism and response.

Daly AK, Aithal GP. Daly AK, et al. Among authors: aithal gp. Semin Vasc Med. 2003 Aug;3(3):231-8. doi: 10.1055/s-2003-44458. Semin Vasc Med. 2003. PMID: 15199455 Review.

5

Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism.

King BP, Khan TI, Aithal GP, Kamali F, Daly AK. King BP, et al. Among authors: aithal gp. Pharmacogenetics. 2004 Dec;14(12):813-22. doi: 10.1097/00008571-200412000-00004. Pharmacogenetics. 2004. PMID: 15608560

6

Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.

Daly AK, Aithal GP, Leathart JB, Swainsbury RA, Dang TS, Day CP. Daly AK, et al. Among authors: aithal gp. Gastroenterology. 2007 Jan;132(1):272-81. doi: 10.1053/j.gastro.2006.11.023. Epub 2006 Nov 17. Gastroenterology. 2007. PMID: 17241877

7

Nonsteroidal anti-inflammatory drug-induced hepatotoxicity.

Aithal GP, Day CP. Aithal GP, et al. Clin Liver Dis. 2007 Aug;11(3):563-75, vi-vii. doi: 10.1016/j.cld.2007.06.004. Clin Liver Dis. 2007. PMID: 17723920 Review.

8

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.

Guha IN, Parkes J, Roderick P, Chattopadhyay D, Cross R, Harris S, Kaye P, Burt AD, Ryder SD, Aithal GP, Day CP, Rosenberg WM. Guha IN, et al. Among authors: aithal gp. Hepatology. 2008 Feb;47(2):455-60. doi: 10.1002/hep.21984. Hepatology. 2008. PMID: 18038452

9

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe'er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR, Graham J, Park BK, Dillon JF, Bernal W, Cordell HJ, Pirmohamed M, Aithal GP, Day CP; DILIGEN Study; International SAE Consortium. Daly AK, et al. Among authors: aithal gp. Nat Genet. 2009 Jul;41(7):816-9. doi: 10.1038/ng.379. Epub 2009 May 31. Nat Genet. 2009. PMID: 19483685

10

A role for the pregnane X receptor in flucloxacillin-induced liver injury.

Andrews E, Armstrong M, Tugwood J, Swan D, Glaves P, Pirmohamed M, Aithal GP, Wright MC, Day CP, Daly AK. Andrews E, et al. Among authors: aithal gp. Hepatology. 2010 May;51(5):1656-64. doi: 10.1002/hep.23549. Hepatology. 2010. PMID: 20222094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters